Cite
Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug?
MLA
Lars Eckardt, et al. “Effective Suppression of Atrial Fibrillation by Ivabradine: Novel Target for an Established Drug?” International Journal of Cardiology, vol. 236, June 2017, pp. 237–43. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bfb16485eb4ff2987fc76d0d7265361f&authtype=sso&custid=ns315887.
APA
Lars Eckardt, Nils Bögeholz, Christian Pott, Magdalena Sterneberg, Dirk G. Dechering, Christian Ellermann, Michael Fehr, Gerrit Frommeyer, & Simon Kochhäuser. (2017). Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug? International Journal of Cardiology, 236, 237–243.
Chicago
Lars Eckardt, Nils Bögeholz, Christian Pott, Magdalena Sterneberg, Dirk G. Dechering, Christian Ellermann, Michael Fehr, Gerrit Frommeyer, and Simon Kochhäuser. 2017. “Effective Suppression of Atrial Fibrillation by Ivabradine: Novel Target for an Established Drug?” International Journal of Cardiology 236 (June): 237–43. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bfb16485eb4ff2987fc76d0d7265361f&authtype=sso&custid=ns315887.